General Information of the Compound
| Compound ID |
CP0383186
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-Bromo-N-hydroxy-benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
1836-27-7
4-Bromo-N-hydroxy-benzamide
4-Bromo-N-hydroxybenzamide
4-Bromo-N-hydroxybenzamide #
4-bromobenzenecarbohydroxamic acid
AC1LCOKZ
AKOS000175576
BDBM50015106
Benzamide, 4-bromo-N-hydroxy-
CHEMBL351337
CTK0E2598
DA-16649
DTXSID20345349
FT-0708429
KB-290158
MCULE-4510290140
MolPort-002-985-506
N-Hydroxy-4-bromobenzamide
SC-53612
SCHEMBL8575405
ST51029575
STK249669
VESPFSJNQMGUCQ-UHFFFAOYSA-N
ZINC5249551
p-Bromobenzohydroxamic acid
p-bromophenylhydroxamic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C7H6BrNO2
|
||||||||||||||||||
| Molecular Weight |
216.034
|
||||||||||||||||||
| Canonical SMILES |
ONC(=O)c1ccc(Br)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C7H6BrNO2/c8-6-3-1-5(2-4-6)7(10)9-11/h1-4,11H,(H,9,10)
Show/Hide
|
||||||||||||||||||
| InChIKey |
VESPFSJNQMGUCQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound